⌘K
Loading ticker…
As of 2026-08-24, Oscar Health, Inc. (OSCR) has a 3-month relative strength percentile of 91 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 78. The current market Stance is 47.8 (Neutral). Sector: Financials, ranked 4 of 11. Average daily range 6.2%, relative volume 0.78×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
OSCR is in a stage 2 uptrend, week 2. Currently in a 6-day base; basing ADR 5.7% (broad 5.9%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 5.9% / 60.7%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
OSCR is held by 32 ETFs as of May 2026. Top owner: AVUV at 0.53% weight, $143M notional. Top 3 carry $190M.
Held by 79 ETFs · $610M across latest filings · largest weight 5.75% (MNVT).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVUVAvantis U.S. Small Cap Value ETF | 0.53% | $143M | +0.19 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.10% | $23M | +0.03 pp |
| VTWO | 0.13% | $23M | +0.04 pp |
| AVLVAvantis U.S. Large Cap Value ETF | 0.10% | $13M | +0.10 pp |
| VFH |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.05% |
| $7M |
| +0.02 pp |
| VTWG | 0.25% | $4M | +0.08 pp |
| AVUSAvantis U.S. Equity ETF | 0.03% | $4M | — |
| CLSE | 0.48% | $3M | new |
| SCHBSchwab U.S. Broad Market ETF | 0.01% | $3M | — |
| FNDA | 0.03% | $2M | new |
Showing 10 of 32 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | OSCR Jan avg: 29.07% median: 30.17% win: 75% σ: 23.63% n: 4 2022-04-12 → 2026-07-31 | OSCR Feb avg: 14.30% median: 12.46% win: 50% σ: 27.09% n: 4 2022-04-12 → 2026-07-31 | OSCR Mar avg: -4.17% median: -9.41% win: 25% σ: 15.14% n: 4 2022-04-12 → 2026-07-31 | OSCR Apr avg: 13.22% median: 2.90% win: 60% σ: 28.82% n: 5 2022-04-12 → 2026-07-31 | OSCR May avg: 3.25% median: 9.06% win: 80% σ: 21.67% n: 5 2022-04-12 → 2026-07-31 | OSCR Jun avg: 12.11% median: 9.81% win: 60% σ: 30.85% n: 5 2022-04-12 → 2026-07-31 | OSCR Jul avg: 1.42% median: 9.47% win: 60% σ: 23.36% n: 5 2022-04-12 → 2026-07-31 | OSCR Aug avg: 7.06% median: 11.04% win: 75% σ: 17.82% n: 4 2022-04-12 → 2026-07-31 (current) | OSCR Sep avg: -1.59% median: 1.23% win: 50% σ: 19.71% n: 4 2022-04-12 → 2026-07-31 | OSCR Oct avg: -14.76% median: -14.44% win: 0% σ: 9.80% n: 4 2022-04-12 → 2026-07-31 | OSCR Nov avg: 11.55% median: 1.49% win: 50% σ: 38.09% n: 4 2022-04-12 → 2026-07-31 | OSCR Dec avg: -12.35% median: -17.31% win: 25% σ: 13.73% n: 4 2022-04-12 → 2026-07-31 |